Jinxia Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinxia Wei has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Yubo Li
School of Chinese Materia Medica Tianjin University of Traditional Chinese Medicine Tianjin China
6 shared publications - Jia Shao
Department of Pharmacy, Tianjin First Central Hospital, Tianjin, China
2 shared publications Yue Zhang
School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China
2 shared publications- Aihong Yang
School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China
1 shared publication - Fang Wang
School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China
1 shared publication Huimin Liu
School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
1 shared publication
Latest Publications
- Open Access
- 29 August 2026
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 19, 6472025
Comparative pharmacokinetics and hippocampal distribution of six major bioactive alkaloids in normal and Alzheimer’s disease rats after oral administration of Menispermi Rhizoma extract
Menispermi Rhizoma (MR), officially listed in the Chinese Pharmacopoeia, contains abundant and diverse alkaloids with significant therapeutic effects against Alzheimer’s disease (AD). However, the pharmacokinetic characteristics and hippocampal distribution of its major bioactive alkaloids in rats under different physiopathological conditions remain unclear. In this study, a systematic qualitative analysis of alkaloids in plasma and brain tissue of AD rats following oral administration of MR extract was performed by ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS). Subsequently, a sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed and validated to compare the pharmacokinetics and hippocampal distribution of six bioactive alkaloids (dauricine, daurisoline, dauricicoline, acutumidine, dauricoside, and 6- O -demethylmenisporphine) in sham-operated and AD rats. A total of 24 prototype alkaloids in the plasma and brain tissue of AD rats were identified. Pharmacokinetic analysis revealed that the C max , the area under the plasma concentration–time curve to the last measurable plasma concentration (AUC 0-t ), and the area under the plasma concentration–time curve to time infinity (AUC 0-∞ ) of acutumidine and 6- O -demethylmenisporphine were obviously increased in AD rats compared to sham-operated rats. Similar trends were observed for dauricine and dauricoside, suggesting enhanced absorption and delayed elimination. These changes may be attributed to the inhibition of drug-metabolizing enzymes and transporters in the gastrointestinal tract and liver or the reduced renal clearance under pathological states. Furthermore, all six alkaloids successfully crossed the blood-brain barrier and accumulated in the hippocampus. Notably, hippocampal drug concentrations were higher in sham-operated rats than in AD rats, likely reflecting the degeneration and cellular damage of hippocampal neurons in the disease state. These findings lay a robust foundation for elucidating the pharmacodynamic material basis of MR in treating AD.
- 29 August 2026
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 19, 6472025
Open AccessComparative pharmacokinetics and hippocampal distribution of six major bioactive alkaloids in normal and Alzheimer’s disease rats after oral administration of Menispermi Rhizoma extract
Menispermi Rhizoma (MR), officially listed in the Chinese Pharmacopoeia, contains abundant and diverse alkaloids with significant therapeutic effects against Alzheimer’s disease (AD). However, the pharmacokinetic characteristics and hippocampal distribution of its major bioactive alkaloids in rats under different physiopathological conditions remain unclear. In this study, a systematic qualitative analysis of alkaloids in plasma and brain tissue of AD rats following oral administration of MR extract was performed by ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS). Subsequently, a sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed and validated to compare the pharmacokinetics and hippocampal distribution of six bioactive alkaloids (dauricine, daurisoline, dauricicoline, acutumidine, dauricoside, and 6- O -demethylmenisporphine) in sham-operated and AD rats. A total of 24 prototype alkaloids in the plasma and brain tissue of AD rats were identified. Pharmacokinetic analysis revealed that the C max , the area under the plasma concentration–time curve to the last measurable plasma concentration (AUC 0-t ), and the area under the plasma concentration–time curve to time infinity (AUC 0-∞ ) of acutumidine and 6- O -demethylmenisporphine were obviously increased in AD rats compared to sham-operated rats. Similar trends were observed for dauricine and dauricoside, suggesting enhanced absorption and delayed elimination. These changes may be attributed to the inhibition of drug-metabolizing enzymes and transporters in the gastrointestinal tract and liver or the reduced renal clearance under pathological states. Furthermore, all six alkaloids successfully crossed the blood-brain barrier and accumulated in the hippocampus. Notably, hippocampal drug concentrations were higher in sham-operated rats than in AD rats, likely reflecting the degeneration and cellular damage of hippocampal neurons in the disease state. These findings lay a robust foundation for elucidating the pharmacodynamic material basis of MR in treating AD.
- 7 June 2026
- Published by Elsevier in Journal of Chromatography B
- Vol. 1281, 125165
A simple LC-MS/MS method for the simultaneous determination of 18 free fatty acids in human serum
- 7 June 2026
- Published by Elsevier in Journal of Chromatography B
- Vol. 1281, 125165
A simple LC-MS/MS method for the simultaneous determination of 18 free fatty acids in human serum
- 3 October 2024
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 34 (3) , 547-562
Dietary herbs that interact with gut microbiota: roles as anti-stroke agents
Growing evidence suggests that dietary herbs can prevent stroke by regulating the composition and structure of gut microbiota. The components of dietary herbs can also be metabolized or converted into bioactive molecules for treating stroke by gut microbiota, and exert therapeutic effects by inhibiting inflammation, oxidative stress, apoptosis, and other processes caused by stroke. A deep understanding of the mechanism of gut microbiota-mediated dietary herbal intervention in stroke is of great significance for the treatment and drug screening of stroke diseases. In this review, we summarise the complex bidirectional relationship between stroke and gut microbiota and provide a detailed introduction to the mechanism of the interaction between dietary herbs and gut microbiota in intervening in stroke. In addition, we also discuss the limitations of current research and potential directions in this field, hoping to provide ideas and references for the treatment and drug development of stroke diseases. Graphical abstract Dietary herbs and active ingredients can balance the intestinal microbiota disorders in stroke patients or models, and herbal ingredients can be converted into more easily absorbed active substances under the action of microorganisms, thereby exerting therapeutic effect on stroke diseases
- 3 October 2024
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 34 (3) , 547-562
Dietary herbs that interact with gut microbiota: roles as anti-stroke agents
Growing evidence suggests that dietary herbs can prevent stroke by regulating the composition and structure of gut microbiota. The components of dietary herbs can also be metabolized or converted into bioactive molecules for treating stroke by gut microbiota, and exert therapeutic effects by inhibiting inflammation, oxidative stress, apoptosis, and other processes caused by stroke. A deep understanding of the mechanism of gut microbiota-mediated dietary herbal intervention in stroke is of great significance for the treatment and drug screening of stroke diseases. In this review, we summarise the complex bidirectional relationship between stroke and gut microbiota and provide a detailed introduction to the mechanism of the interaction between dietary herbs and gut microbiota in intervening in stroke. In addition, we also discuss the limitations of current research and potential directions in this field, hoping to provide ideas and references for the treatment and drug development of stroke diseases. Graphical abstract Dietary herbs and active ingredients can balance the intestinal microbiota disorders in stroke patients or models, and herbal ingredients can be converted into more easily absorbed active substances under the action of microorganisms, thereby exerting therapeutic effect on stroke diseases
- Open Access
- 9 August 2022
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 10, 926950
Study on the potential mechanism of the active components in YiYiFuZi powder in homotherapy for hetropathy of coronary heart disease and rheumatoid arthritis
In recent years, the incidence of coronary heart disease and rheumatoid arthritis has been increasing, which has become a common public health problem worldwide. YiYiFuZi (YYFZ ) powder is a classical traditional Chinese prescription, which is commonly used to treat metabolic diseases such as rheumatoid arthritis, with an ideal curative effect, but the therapeutic mechanism is still unclear. In this study, from the perspective of clinical metabolomics, combined with network pharmacology, we sought the comorbidity mechanism and key targets of coronary heart disease and rheumatoid arthritis and the mechanism by which YYFZ powder exerts therapeutic effects, combined with molecular docking and atomic force microscopy to determine the effective components, and found that the higenamine and steroid components in YYFZ powder can bind acid sphingomyelinase enzymes to affect the sphingolipid pathway to produce therapeutic effects, which can bind to sugars existing as a glycoside.
- 9 August 2022
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 10, 926950
Open AccessStudy on the potential mechanism of the active components in YiYiFuZi powder in homotherapy for hetropathy of coronary heart disease and rheumatoid arthritis
In recent years, the incidence of coronary heart disease and rheumatoid arthritis has been increasing, which has become a common public health problem worldwide. YiYiFuZi (YYFZ ) powder is a classical traditional Chinese prescription, which is commonly used to treat metabolic diseases such as rheumatoid arthritis, with an ideal curative effect, but the therapeutic mechanism is still unclear. In this study, from the perspective of clinical metabolomics, combined with network pharmacology, we sought the comorbidity mechanism and key targets of coronary heart disease and rheumatoid arthritis and the mechanism by which YYFZ powder exerts therapeutic effects, combined with molecular docking and atomic force microscopy to determine the effective components, and found that the higenamine and steroid components in YYFZ powder can bind acid sphingomyelinase enzymes to affect the sphingolipid pathway to produce therapeutic effects, which can bind to sugars existing as a glycoside.
- Open Access
- 19 May 2022
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 10, 869972
Integrated Serum Pharmacochemistry and Network Pharmacology Approach to Explore the Effective Components and Potential Mechanisms of Menispermi Rhizoma Against Myocardial Ischemia
Background: Myocardial ischemia (MI) is a leading cause of death worldwide. Menispermi Rhizoma is a traditional Chinese medicine that exerts a variety of beneficial pharmacological activities in many diseases, including MI.Purpose: Serum pharmacochemistry and network pharmacology were used to explore the material basis and mechanism of action of Menispermi Rhizoma against MI.Methods: The absorbed components of Menispermi Rhizoma in rat plasma were analyzed by ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF/MS). The key components, targets, pathways, and interrelated information were obtained by network pharmacology. The potential effective components of Menispermi Rhizoma against MI were screened by methyl-thiazolyl-tetrazolium (MTT) assay, and the cardioprotective effect and mechanism of active components were verified by Western blotting and molecular docking.Results: In total, 25 absorbed components of Menispermi Rhizoma in plasma were identified. Network pharmacology revealed 81 major targets of Menispermi Rhizoma against MI, mainly involving the regulation of the PI3K/AKT and MAPK pathways. In vitro validation of H9c2 cells revealed that acutumine, daurisoline, dauricoside, and 6-O-demethylmenisporphine are the main bioactive components of Menispermi Rhizoma. The levels of lactate dehydrogenase, creatine kinase, and malondialdehyde (MDA) were significantly decreased by four alkaloids, whereas the activities of superoxide dismutase (SOD) and glutathione (GSH) were significantly increased. Four alkaloids effectively protected H9c2 cells against OGD-induced apoptosis by Hoechst/PI staining and flow cytometry assay. Western blotting results showed that the four alkaloids upregulated the expression ratio of Bcl-2/Bax and downregulated the expression levels of Cyt-C and cleaved caspase 3, which further supported the anti-cardiomyocyte apoptosis and antioxidative stress effect of Menispermi Rhizoma. Molecular docking confirmed that the four compounds were capable of binding to AKT1, MAPK1, EGFR, CASP3, and MAPK8 proteins, suggesting the protective effect of Menispermi Rhizoma on MI via PI3K/AKT, MAPK, and apoptosis pathways.Conclusion: Menispermi Rhizoma exerted cardioprotective effects through the effect characteristics: multiple-ingredient, multi-target, and multi-pathway. This research provided a reference for further mechanistic research on wider applications of Menispermi Rhizoma for MI treatment.
- 19 May 2022
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 10, 869972
Open AccessIntegrated Serum Pharmacochemistry and Network Pharmacology Approach to Explore the Effective Components and Potential Mechanisms of Menispermi Rhizoma Against Myocardial Ischemia
Background: Myocardial ischemia (MI) is a leading cause of death worldwide. Menispermi Rhizoma is a traditional Chinese medicine that exerts a variety of beneficial pharmacological activities in many diseases, including MI.Purpose: Serum pharmacochemistry and network pharmacology were used to explore the material basis and mechanism of action of Menispermi Rhizoma against MI.Methods: The absorbed components of Menispermi Rhizoma in rat plasma were analyzed by ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF/MS). The key components, targets, pathways, and interrelated information were obtained by network pharmacology. The potential effective components of Menispermi Rhizoma against MI were screened by methyl-thiazolyl-tetrazolium (MTT) assay, and the cardioprotective effect and mechanism of active components were verified by Western blotting and molecular docking.Results: In total, 25 absorbed components of Menispermi Rhizoma in plasma were identified. Network pharmacology revealed 81 major targets of Menispermi Rhizoma against MI, mainly involving the regulation of the PI3K/AKT and MAPK pathways. In vitro validation of H9c2 cells revealed that acutumine, daurisoline, dauricoside, and 6-O-demethylmenisporphine are the main bioactive components of Menispermi Rhizoma. The levels of lactate dehydrogenase, creatine kinase, and malondialdehyde (MDA) were significantly decreased by four alkaloids, whereas the activities of superoxide dismutase (SOD) and glutathione (GSH) were significantly increased. Four alkaloids effectively protected H9c2 cells against OGD-induced apoptosis by Hoechst/PI staining and flow cytometry assay. Western blotting results showed that the four alkaloids upregulated the expression ratio of Bcl-2/Bax and downregulated the expression levels of Cyt-C and cleaved caspase 3, which further supported the anti-cardiomyocyte apoptosis and antioxidative stress effect of Menispermi Rhizoma. Molecular docking confirmed that the four compounds were capable of binding to AKT1, MAPK1, EGFR, CASP3, and MAPK8 proteins, suggesting the protective effect of Menispermi Rhizoma on MI via PI3K/AKT, MAPK, and apoptosis pathways.Conclusion: Menispermi Rhizoma exerted cardioprotective effects through the effect characteristics: multiple-ingredient, multi-target, and multi-pathway. This research provided a reference for further mechanistic research on wider applications of Menispermi Rhizoma for MI treatment.
- Open Access
- 4 January 2021
- Published by Springer Nature in Journal of Analytical Science and Technology
- Vol. 12 (1) , 1-9
A sensitive HPLC-FLD method for the quantification of 6-O-demethylmenisporphine isolated from Menispermi Rhizoma in rat plasma
Background: To investigate the pharmacokinetics of 6-O-demethylmenisporphine, an oxoisoaporphine alkaloid with significant anti-tumor activities and isolated from Menispermi Rhizoma, a novel and sensitive HPLC assay was established for 6-O-demethylmenisporphine quantification in rat plasma. Methods: Peak responses were detected by a highly selective and sensitive fluorescence detector with 426-nm excitation and 514-nm emission wavelengths. Curcumin was employed as the internal standard (IS). A Capcell Pak C18 column (150 mm × 4.6 mm i.d., 5 μm) and an isocratic elution procedure with a flow rate of 1.0 mL/min were used to exclude the endogenous interfering substance. Acetonitrile-water (68:32, v/v) containing 1% formic acid was employed as mobile phase. A 7-point calibration curve that covered the concentration range of 10–2500 ng/mL was constructed. Results: A good linearity was observed with a correlation coefficient (r) of 0.9993. The lower limit of quantification for 6-O-demethylmenisporphine was 10 ng/mL. The mean recoveries of analyte in rat plasma exceeded 80.5%. The precision at four concentration levels was within 11.3% and the accuracy ranged from − 7.6 to 6.7%. Conclusion: Using this new HPLC-FLD method, the investigation of plasma samples from rats following oral dosing of neat compound and Menispermi Rhizoma extract was successfully conducted. The results will provide a reference for the evaluation of preclinical safety of 6-O-demethylmenisporphine.
- 4 January 2021
- Published by Springer Nature in Journal of Analytical Science and Technology
- Vol. 12 (1) , 1-9
Open AccessA sensitive HPLC-FLD method for the quantification of 6-O-demethylmenisporphine isolated from Menispermi Rhizoma in rat plasma
Background: To investigate the pharmacokinetics of 6-O-demethylmenisporphine, an oxoisoaporphine alkaloid with significant anti-tumor activities and isolated from Menispermi Rhizoma, a novel and sensitive HPLC assay was established for 6-O-demethylmenisporphine quantification in rat plasma. Methods: Peak responses were detected by a highly selective and sensitive fluorescence detector with 426-nm excitation and 514-nm emission wavelengths. Curcumin was employed as the internal standard (IS). A Capcell Pak C18 column (150 mm × 4.6 mm i.d., 5 μm) and an isocratic elution procedure with a flow rate of 1.0 mL/min were used to exclude the endogenous interfering substance. Acetonitrile-water (68:32, v/v) containing 1% formic acid was employed as mobile phase. A 7-point calibration curve that covered the concentration range of 10–2500 ng/mL was constructed. Results: A good linearity was observed with a correlation coefficient (r) of 0.9993. The lower limit of quantification for 6-O-demethylmenisporphine was 10 ng/mL. The mean recoveries of analyte in rat plasma exceeded 80.5%. The precision at four concentration levels was within 11.3% and the accuracy ranged from − 7.6 to 6.7%. Conclusion: Using this new HPLC-FLD method, the investigation of plasma samples from rats following oral dosing of neat compound and Menispermi Rhizoma extract was successfully conducted. The results will provide a reference for the evaluation of preclinical safety of 6-O-demethylmenisporphine.
- 24 April 2017
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 9 (20) , 3029-3038
Rapid and simultaneous determination of 22 constituents in Menispermi Rhizoma by ultra-performance liquid chromatography tandem triple quadrupole mass spectrometry
A multi-component-assay quality control method, using ultra-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry, has been developed for the simultaneous quantification of 22 constituents in Menispermi Rhizoma. By employing a Waters BEH C18 column (50 mm × 2.1 mm, i.d., 1.7 μm), 22 constituents were separated within only 14 min using a gradient elution system consisting of acetonitrile and 0.1% aqueous formic acid at a flow rate of 0.3 mL min−1. Mass spectrometric detection was performed using multiple reaction monitoring mode via an electrospray ionization source operating in positive ionization mode. The validation of the method, including linearity, sensitivity, precision, accuracy and stability, was carried out and demonstrated to satisfy the requirements of quantitative analysis. The developed method was successfully applied for the simultaneous quantification of 22 components in 10 batches of Menispermi Rhizoma obtained from different regions of northern China, and the results showed that the contents of analytes in Menispermi Rhizoma from different sources varied widely. Hierarchical cluster analysis was performed to differentiate and classify the samples based on the contents of the 22 characteristic constituents, which is helpful for the comprehensive evaluation of the quality of Menispermi Rhizoma.
- 24 April 2017
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 9 (20) , 3029-3038
Rapid and simultaneous determination of 22 constituents in Menispermi Rhizoma by ultra-performance liquid chromatography tandem triple quadrupole mass spectrometry
A multi-component-assay quality control method, using ultra-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry, has been developed for the simultaneous quantification of 22 constituents in Menispermi Rhizoma. By employing a Waters BEH C18 column (50 mm × 2.1 mm, i.d., 1.7 μm), 22 constituents were separated within only 14 min using a gradient elution system consisting of acetonitrile and 0.1% aqueous formic acid at a flow rate of 0.3 mL min−1. Mass spectrometric detection was performed using multiple reaction monitoring mode via an electrospray ionization source operating in positive ionization mode. The validation of the method, including linearity, sensitivity, precision, accuracy and stability, was carried out and demonstrated to satisfy the requirements of quantitative analysis. The developed method was successfully applied for the simultaneous quantification of 22 components in 10 batches of Menispermi Rhizoma obtained from different regions of northern China, and the results showed that the contents of analytes in Menispermi Rhizoma from different sources varied widely. Hierarchical cluster analysis was performed to differentiate and classify the samples based on the contents of the 22 characteristic constituents, which is helpful for the comprehensive evaluation of the quality of Menispermi Rhizoma.